7. Systemic Lupus Erythematosus Flashcards

1
Q

What diseases come under the category of ‘connective tissue disease’?

A
SLE  
Systemic sclerosis  
Dermatomyositis/polymyositis  
Sjogren’s syndrome  
Mixed connective tissue disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which gender does SLE more commonly affect?

A

Females 9:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the presentation of SLE including some specific features.

A
Malaise, fatigue, weight loss, fever, lymphadenopathy  
Specific features:  
Butterfly rash
Alopecia  
Arthralgia  
Long history of Raynaud’s phenomenon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the characteristics of the rash seen in SLE.

A

It tends to go across the nose
It may look a bit like acne
It is not painful or itchy
Some rashes become depigmented when the inflammation spreads to the dermis (depigmentation and scarring is irreversible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the pathogenesis of SLE.

A

SLE patients have a defect in apoptosis
Apoptotic cells are not cleared properly so they persist and expose their nuclear antigens and autoantibodies are generated against these nuclear antigens
The defect in apoptosis is combined with B cell hyperactivity
The overactive B cells are exposed to the nuclear antigens and the plasma cells begin to produce autoantibodies that circulate and form immune complexes
The immune complexes deposit in tissues and activate complement leading to inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the first investigation performed in the diagnosis of SLE?

A

Check for anti-nuclear antibodies (this is not specific for SLE though)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The pattern with which the antinuclear antibodies bind to the nuclear antigens is important in reaching a diagnosis. List some different patterns and the antigens they are associated with.

A

Homogenous – DNA
Speckled – antibodies to Ro, La, Sm and RNP
Nucleolar – topoisomerase – scleroderma
Centromere – limited cutaneous scleroderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What conditions are associated with the presence of anti-Ro and anti-La antibodies?

A

Neonatal lupus syndrome

Subacute cutaneous lupus erythematosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some other tests that can be done for SLE?

A

Measuring complement levels
Anti-cardiolipin antibodies
Lupus anticoagulant
Beta 1 glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the haematological features of SLE.

A
SLE is generally associated with low blood counts  
Thrombocytopenia  
Lymphopenia  
Normocytic anaemia  
Autoimmune haemolytic anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What renal changes might occur in SLE?

A

Proteinuria
Haematuria
Active urinary sediment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List some clinical features that could help pre-empt severe attacks in SLE.

A

Malaise, weight loss, alopecia, rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List some laboratory markers that could help pre-empt severe attacks in SLE.

A

Raised ESR
Raised anti-dsDNA antibodies
Reduced complement levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the differences between mild, moderate and severe disease in SLE.

A

Mild – skin and joint involvement
Moderate – inflammation of other organs (e.g. pleuritis, pericarditis)
Severe – severe inflammation of vital organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the treatment of mild disease.

A

Paracetamol and NSAIDs
Hydroxychloroquine (good for arthropathy and cutaneous manifestations)
Topical corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the treatment of moderate disease.

A

ORAL GLUCORTICOIDS

Start with a HIGH dose and titre downwards

17
Q

Describe the treatment of severe disease.

A

Azathioprine – useful steroid-sparing drug
Has a risk of neutropenia/bone marrow suppression so needs regular blood monitoring
Cyclophosphamide – one used if there is severe organ involvement
Problem – infertility

18
Q

Name and explain the mechanism of action of two new treatments for severe disease.

A

Mycophenolate mofetil
 Reversible inhibitor of inosine monophosphate dehydrogenase
 This is the rate limiting step in de novo purine synthesis
 Lymphocytes rely heavily on de novopurine synthesisRituximab
 Anti-CD20 antibody
 Causes depletion of B cells
 Useful in lupus nephritis

19
Q

SLE has and early peak and a late peak in mortality. What are the usual causes of the two peaks?

A

Early – renal failure, CNS disease, infection

Late – MI and stroke

20
Q

What can usually be seen on the blood film of a patient with SLE?

A
Schistocytes (evidence of microangiopathic haemolytic anaemia) 
Teardrop cells  
Spherocytes  
Few leukocytes  
Few platelets
21
Q

Describe the appearance of a renal biopsy in a patient with SLE

A

Hypercellular
Mesangial proliferation
Crescent development